Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neutropenia × eravacycline × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neutropenia 1 Hematologic Neoplasms 1

Interventions

pegylated granulocyte colony-stimulating factor 2 trilaciclib 1 plerixafor 1 eravacycline 1 ceftolozane, tazobactam drug combination 1 Piperacillin, Tazobactam Drug Combination 1 PM 01183 1 Loratadine 1 Blood Specimen Collection 1 Antiviral Agents 1 Antifungal Agents 1 Anti-Infective Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05537896 2026-04-16

Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia

West Virginia University

Phase 2 Recruiting

Other hematologic neoplasm

Neutropenia, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡